Substituted pyrrolopyridines as inhibitors of activin receptor-like kinase
US11236086B2 · kind B2 · utility
1Cited by
23References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 18, 2018 |
| Grant date | Feb 1, 2022 |
| Priority date | — |
| Expiry date | Oct 18, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Described herein are compounds that inhibit ALK2 and its mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.